Building 40A will be a six story, 158,141 GSF addition to the Building 40 NIAID Vaccine Research Center (VRC). Building 40A will double the available laboratory space of the VRC, and it will house BSL-2 and specialty laboratories, laboratory support space, administrative support space, and conference/meeting rooms. The VRC is in the forefront of developing vaccines for infectious disease threats, including coronaviruses (SARS-CoV-2, MERS-CoV, SARS-CoV), influenza, HIV/AIDS, and Ebola. The VRC is frequently called upon to address biodefense threats and global pandemic emerging infectious disease threats.
Project Officer: Maya M. Kai Kai
Support: James Cameron, Melinda Alexander, Dhanika Ranasinghe, Chuck Boehmer
Completion: September 2024